Nicholas A. Pullen, Ph.D.
Affiliations: | 2010 | Anatomy & Neurobiology | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Cell Biology, Neuroscience BiologyGoogle:
"Nicholas Pullen"Mean distance: 35622
Parents
Sign in to add mentor| Helen L. Fillmore | grad student | 2010 | VCU | |
| (The influences of matrix metalloproteinase-1 expression on glioblastoma pathology.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lyons DO, Pullen NA. (2020) Beyond IgE: Alternative Mast Cell Activation Across Different Disease States. International Journal of Molecular Sciences. 21 |
| Orsolic I, Jurada D, Pullen N, et al. (2015) The relationship between the nucleolus and cancer: Current evidence and emerging paradigms. Seminars in Cancer Biology |
| Faber TW, Pullen NA, Fernando JF, et al. (2014) ADAM10 is required for SCF-induced mast cell migration. Cellular Immunology. 290: 80-8 |
| Morales JK, Saleem SJ, Martin RK, et al. (2014) Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses. Journal of Leukocyte Biology. 95: 643-50 |
| Fernando J, Faber TW, Pullen NA, et al. (2013) Genotype-dependent effects of TGF-β1 on mast cell function: targeting the Stat5 pathway. Journal of Immunology (Baltimore, Md. : 1950). 191: 4505-13 |
| Villalta SA, Lang J, Kubeck S, et al. (2013) Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function. Diabetes. 62: 2870-8 |
| Kay LJ, Gilbert M, Pullen N, et al. (2013) Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells. Clinical and Experimental Allergy : Journal of the British Society For Allergy and Clinical Immunology. 43: 741-51 |
| Atkinson JM, Pullen N, Johnson TS. (2013) An inhibitor of thrombin activated fibrinolysis inhibitor (TAFI) can reduce extracellular matrix accumulation in an in vitro model of glucose induced ECM expansion. Matrix Biology : Journal of the International Society For Matrix Biology. 32: 277-87 |
| Pullen NA, Falanga YT, Morales JK, et al. (2012) The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling. Frontiers in Immunology. 3: 117 |
| Elberg D, Turman MA, Pullen N, et al. (2012) Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells. Prostaglandins & Other Lipid Mediators. 98: 11-16 |